ArticleJournal of clinical medicine2026
Prognostic Value of the Lung Immune Prognostic Index and an ECOG-Albumin-LIPI Nomogram in Metastatic NSCLC Patients Treated with Second- or Third-Line Nivolumab.
Didem Divriklioğlu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.